BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 28069330)

  • 1. TOP2A, HELLS, ATAD2, and TET3 Are Novel Prognostic Markers in Renal Cell Carcinoma.
    Chen D; Maruschke M; Hakenberg O; Zimmermann W; Stief CG; Buchner A
    Urology; 2017 Apr; 102():265.e1-265.e7. PubMed ID: 28069330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
    Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C
    BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.
    Ip JC; Pang TC; Glover AR; Soon P; Zhao JT; Clarke S; Robinson BG; Gill AJ; Sidhu SB
    Oncologist; 2015 Mar; 20(3):247-56. PubMed ID: 25657202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer.
    Nuncia-Cantarero M; Martinez-Canales S; Andrés-Pretel F; Santpere G; Ocaña A; Galan-Moya EM
    Breast Cancer Res Treat; 2018 Apr; 168(3):613-623. PubMed ID: 29330624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high expression of TOP2A indicates poor prognosis and is associated with immune infiltration in kidney renal clear cell carcinoma.
    Song S; Lou K; Lun J; Cui Y
    Asian J Surg; 2024 Mar; 47(3):1493-1494. PubMed ID: 38065734
    [No Abstract]   [Full Text] [Related]  

  • 6. MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting
    Ji S; Su X; Zhang H; Han Z; Zhao Y; Liu Q
    Oncol Lett; 2019 Feb; 17(2):2400-2408. PubMed ID: 30719113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-30c-2-3p suppresses the proliferation of human renal cell carcinoma cells by targeting TOP2A.
    Huang X; Jia Y; Shi H; Fan H; Sun L; Zhang H; Wang Y; Chen J; Han J; Wang M; Du J; Zhang J
    Asian Biomed (Res Rev News); 2023 Jun; 17(3):124-135. PubMed ID: 37818158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
    Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
    MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of bromodomain proteins in renal cell carcinoma (Review).
    Wen Q; Liu H; Lou K; Zhang X; Chao W; Xin J; Gong J; Zou J; Zou X
    Mol Med Rep; 2023 Jul; 28(1):. PubMed ID: 37293842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
    Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
    Endocr Pathol; 2023 Mar; 34(1):129-141. PubMed ID: 36656469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Promoting ATAD2 and Its Preclinical Challenges.
    Liu H; Wen Q; Yan S; Zeng W; Zou Y; Liu Q; Zhang G; Zou J; Zou X
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008934
    [No Abstract]   [Full Text] [Related]  

  • 12. A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia.
    Gong H; Li H; Yang Q; Zhang G; Liu H; Ma Z; Peng H; Nie L; Xiao X; Liu J
    Biomed Res Int; 2022; 2022():5646275. PubMed ID: 35845961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.
    Zhou J; Simon JM; Liao C; Zhang C; Hu L; Zurlo G; Liu X; Fan C; Hepperla A; Jia L; Tcheuyap VT; Zhong H; Elias R; Ye J; Henne WM; Kapur P; Nijhawan D; Brugarolas J; Zhang Q
    Mol Cell; 2022 Aug; 82(16):3030-3044.e8. PubMed ID: 35764091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicase lymphoid-specifics and selenoprotein P1 are potential candidate genes in the progression and prognosis of lung adenocarcinoma.
    Tian G; Lin XX; Zhang XM; He Z; Hu ZL
    Transl Cancer Res; 2019 Oct; 8(6):2380-2388. PubMed ID: 35116990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (
    Zhou Y; Li J; Yang X; Song Y; Li H
    Bioengineered; 2021 Dec; 12(2):12003-12022. PubMed ID: 34787052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain.
    Evans CM; Phillips M; Malone KL; Tonelli M; Cornilescu G; Cornilescu C; Holton SJ; Gorjánácz M; Wang L; Carlson S; Gay JC; Nix JC; Demeler B; Markley JL; Glass KC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoid-specific helicase in epigenetics, DNA repair and cancer.
    Chen X; Li Y; Rubio K; Deng B; Li Y; Tang Q; Mao C; Liu S; Xiao D; Barreto G; Tao Y
    Br J Cancer; 2022 Feb; 126(2):165-173. PubMed ID: 34493821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Roles of Bromodomain Proteins in Cancer.
    Boyson SP; Gao C; Quinn K; Boyd J; Paculova H; Frietze S; Glass KC
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker Categorization in Transcriptomic Meta-Analysis by Concordant Patterns With Application to Pan-Cancer Studies.
    Ye Z; Ke H; Chen S; Cruz-Cano R; He X; Zhang J; Dorgan J; Milton DK; Ma T
    Front Genet; 2021; 12():651546. PubMed ID: 34276766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1.
    Li K; Han F; Wu Y; Wang X
    Onco Targets Ther; 2021; 14():3635-3648. PubMed ID: 34113129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.